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Summary This study investigated the hypothesis that inflammatory, regulatory and
antioxidant systems control the redox balance in interstitial lung diseases.
Spontaneous mRNA expression of inflammatory cytokines and redox-active enzymes
was examined in bronchoalveolar lavage (BAL) cells from patients with idiopathic
pulmonary fibrosis (IPF) and sarcoidosis (SARC) using RT-PCR analysis. Pulmonary
oxidative stress was characterized by carbonyl-levels in the soluble BAL-fluid
protein.
Protein carbonyls were normal in SARC, but 2.4-fold increased in IPF. Here, the
protein carbonyls correlated inversely with glutathione peroxidase mRNA. The
message for IL-8 increased 14-fold in IPF and was accompanied by a marked influx of
PMN, while these parameters were not altered in SARC. Levels of IL-10 transcripts
increased in both diseases, but stronger in SARC (33-fold) than in IPF (22-fold),
contributing to a high IL-10/IL-8 mRNA ratio in SARC (0.86) in comparison to IPF
(0.07) and controls (0.04). In SARC but not in IPF, IFN-g mRNA was expressed at high
levels and correlated inversely with the carbonyl levels. In both diseases, IL-1b, TNF-
a, and IL-6 mRNA transcripts remained at baseline level.
In summary, a low IL-10/IL-8 mRNA ratio was paralleled with significant oxidative
stress in IPF, while a high IL-10/IL-8 ratio and enhanced IFN-g expression went along
with a physiological redox-balance in SARC.
& 2004 Elsevier Ltd. All rights reserved.
Introduction
Interstitial lung diseases such as idiopathic pulmon-
ary fibrosis (IPF)1–4 and SARC3,5 have been linked to
an excessive formation of reactive oxygen species
(ROS) arising from the imbalance between ROS-
generating and -scavenging systems. These disor-
ders are characterized by the accumulation of
leukocytes within the lung, followed by progressive
pulmonary inflammation, and subsequent destruc-
tion of alveolar-capillary units. While IPF is
characterized by an increased number of polymor-
phonuclear neutrophils (PMN) in the epithelial
lining fluid,6 SARC is accompanied by the occur-
rence of lymphocytes,7 thus indicating different
pathophysiological mechanisms. The pulmonary
redox imbalance in interstitial lung diseases is
reflected in (a) an increased oxidative status of
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bronchoalveolar lavage (BAL)-fluid proteins defined
by occurrence of methionine sulfoxide1 and carbo-
nyl groups3 in these proteins, (b) a formation of
nitrotyrosine and nitric oxide synthase (iNOS) in the
lungs of IPF patients using immunohistochemistry,4
and (c) an activation of NFkB in mononuclear cells
isolated from the blood of SARC patients.5
So far, little is known concerning the influence of
redox-active enzymes and inflammatory cytokines
on the redox balance in interstitial lung disease.
One of the relevant enzymes that contribute to ROS
formation is the inducible iNOS. Saleh et al.4
recently reported that the radical nitric oxide
(NO), produced by iNOS, is expressed in macro-
phages and PMN from patients with early to
intermediate stages of IPF. Mn dependent super-
oxide dismutase (Mn-SOD), glutathione peroxidase
(GPx), and g-glutamyl-cysteine synthetase (g-GCS)
play a central role in defence of ROS. SOD catalyses
the dismutation from superoxide anion radical (O2
)
to hydrogen peroxide (H2O2), which is further
metabolised by GPx. The latter reaction requires
reduced glutathione (GSH). De novo synthesis of
GSH is dependent on g-GCS, which is the rate-
limiting enzyme of this pathway.8
Among the cytokines, tumour necrosis factor-a
(TNF-a) and interleukin (IL-1b) are potent early
acting pro-inflammatory cytokines that trigger
recruitment of inflammatory cells by inducing the
expression of adhesion molecules and chemokines.9
IL-1b increases proliferation of fibroblasts and may
induce the expression of Mn-SOD.10 IL-8 is a potent
chemoattractant for PMN,11 which represent a
major source for ROS. IL-6 induces T-cell
proliferation and may be, therefore, particularly
relevant to sarcoidosis. On the other hand,
IL-6 inhibits the production of IL-1b and TNF-a
in mononuclear cells,12 and is also known as an
anti-inflammatory mediator.13 IL-10 plays a
crucial role in down-regulating and terminating
inflammation.14 Interferon-g (INF-g) functionally
defines the T helper cell (Th1) response.15 It
inhibits IL-1b and TNF-a induced production of IL-
8 in vitro and may thus control PMN recruitment.16
IL-4 counteracts INF-g and is indicative for the Th2
response.15
The present study was designed to investigate
which of these enzymes and cytokines plays a major
role in the modulation of the redox balance in IPF
and SARC. We found a strongly enhanced message
for IL-8, a normal IL-10/IL-8 ratio, a decreased
message for Mn-SOD associated with a marked
redox imbalance in IPF. A high level of IL-10
message, a high IL-10/IL-8 ratio, and a strong
expression of IFN-g governed the inflammatory
response in SARC.
Materials and methods
Study population
Patients with idiopathic pulmonary fibrosis
In this group nine patients (4 women and 5 men;
mean age 59 years, range 37–74 years; 7 non-
smoker/2 smoker) were studied. The two smoking
patients had more than 24 pack years, respectively.
The diagnosis of IPF was based on medical history,
clinical and physical examinations, chest radio-
graph, HR-CT, pulmonary function test, broncho-
scopy, BAL, and biopsy evidence. Four out of the
nine patients had histological confirmation of usual
interstitial pneumonia, in all other patients fibrosis
was clinically most likely. Two patients received a
steroid therapy with 40mg prednisone at the time
of BAL, respectively.
Patients with sarcoidosis
This group consisted of nine patients (5 women and
4 men; mean age 39 years, range 24–55 years; 7
non-smoker/2 smoker). One of the smoking pa-
tients had more than 24 pack years, and the other
one had 10 pack years. The diagnosis was based on
medical history, clinical and physical examinations,
chest radiograph, pulmonary function test,
bronchoscopy, BAL, and biopsy evidence. By chest
X-ray findings three patients were stage I and six
were stage II. No steroids were taken at the time of
BAL.
Control group
As control subjects, five healthy non-smoking
volunteers (4 women, 1 man; mean age 30 years,
range 22–41 years), were studied. All volunteers
were free of respiratory symptoms and had normal
pulmonary function tests.
BAL
BAL was performed after informed consent was
obtained from each subject. Using a flexible
bronchoscope 3 50ml of sterile warmed saline
was infused into the right middle lope of the lungs
and then was immediately collected by suction.
The BAL fluids recovered were centrifuged at
500 g for 10min to separate BAL cells from the
supernatant. The concentrations of total protein
and oxidized protein were determined in the
supernatant. The cellular fraction was resuspended
in phosphate buffered saline solution and a cell
differential was performed on cytospin prepara-
tions. Remaining BAL cells (o5 106) were again
centrifuged at 500 g for 10min and lysed with
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1ml 4M guanidine thiocyanate, 25mM sodium
acetate, 0.5% sodium laurylsarcosine, and 0.12M
2-mercaptoethanol, pH of 6.0. The lysates were
then sheared with four passes through a 22-gauge
syringe.
RT-PCR
Total cellular RNA was pelleted from BAL cell
lysates by ultracentrifugation through 5.7M cae-
sium chloride and 0.1M EDTA.17 Complementary
DNA (cDNA) was generated from total RNA (0.25 mg/
15 ml) with a RT from the First-Strand cDNA Kit and
the pD (N6) primer (Pharmacia, Germany). The
resultant cDNA was amplified by PCR using 0.01 ml
of the RT reaction for GPx and Mn-SOD, 0.1 ml for
GAPDH, IL-8, IL-1b, and g-GCS, 0.5 ml for TNF-a and
INF-g, 2 ml for IL-6 and IL-10, and 5 ml for iNOS and
IL-4. The respective amounts of the RT reaction
were added to Ready To Go PCR beads (Pharmacia,
Germany) together with the protein-specific 50 and
30 primers. Thirty-five cycles were performed with
a Hybaid Thermal Cycler (Germany) with settings of
30 s at 951C, 1min at the respective annealing
temperature, and 45 s at 721C. Annealing tempera-
tures were 551C for GAPDH, IL-8, g-GCS, TNF-a, INF-
g, IL-4, GPx, and Mn-SOD, 581C for IL-1b and IL-6,
591C for IL-10, and 601C for iNOS.
The following primers were utilised: GAPDH
(product 353 bp): 50 primer: 50-CCA TGA GAA GTA
TGA CAA CAG CC-30, 30 primer, 50-TGG CAG GTT TTT
CTA GAC GG-30 ; IL-1b (product 391 bp): 50 primer:
50-AAA CAG ATG AAG TGC TCC TTC CAG G-30, 30
primer: 50-TGG AGA ACA CCA CTT GTT GCT CCA-30;
TNF-a (product 280 bp): 50 primer, 50-CCA AAG TAG
ACC TGC CCA GA-30, 30 primer, 50-TCT ACT CCC AGG
TCC TCT TCA-30; IL-8 (product 245 bp): 50 primer, 50-
AGC CTT CCT GAT TTC TGC AGC-30, 30 primer, 50-
AAA ACT TCT CCA CAA CCC TCT GC-30; IL-6 (product
330 bp): 50 primer, 50-AGG CAG TGG CAG AAA ACA
ACC-30, 30 primer, 50-GAT GAG TTG TCA TGT CCT
GCA GC-30; IL-10 (product 352 bp): 50 primer, 50-ATG
CCC CAA GCT GAG AAC CAA GAC CCA-30, 30 primer,
50-TCT CAA GGG GCT GGG TCA GCTATC CCA-30; IL-4
(product 303 bp): 50 primer, 50-CAA GTG CGA TAT
CAC CTT ACA GG-30, 30 primer, 50-TTC ACA GGA CAG
GAA TTC AAG C-30; INF-g (product 166 bp): 50
primer, 50-ATG CAG GTC ATT CAG ATG TAG C-30, 30
primer, 50-TCC ACA CTC TTT TGG ATG CTC-30; Mn-
SOD (product 329 bp): 50 primer, 50-CCT GGA ACC
TCA CAT CAA CG-30, 30 primer, 50-AAC CTG AGC CTT
GGA CAC C-30; GPx (product 362 bp): 50 primer, 50-
ACT TAT CGA GAA TGT GGC GTC C-30, 30 primer, 50-
AGG CAA CAT CGT TGC GAC AC-30; g-GCS, heavy
subunit (product 263 bp): 50 primer, 50-CAG CGA
GGA GCT TCA TGA TTG-30, 30 primer, 50-TGA TCA
CAG AAT CCA GCT GTG C-30; iNOS (product 462 bp):
50 primer, 50-ccg agg caa aca gca cat tca g-30, 30
primer, 50-GGT TGG GGG TGT GGT GAT GTC-30.
Quantification of mRNA
We assumed that the mRNA sequences are propor-
tionally represented in the first-strand cDNAs, so
that the relative amount of a cDNA sequence
represent the relative amount of the corresponding
mRNA sequence in the total RNAs. Because we
made no adjustment for RT efficiencies, these
estimates reflect relative rather than absolute
steady-state mRNA levels.
The amplification products were first separated
on a 1.5% agarose gel containing ethidium bromide
and then analysed by a video-densitometer (CCD
camera, and 1D Scan software, MWG, Germany).
For each protein, the integrated densities were
normalized to the ml of RT reaction used in the PCR
and then normalized to the constitutively ex-
pressed enzyme GAPDH (all enzymes and cytokines)
to correct for variation in the amount of amplifiable
cDNA in each sample. Predominantly macrophage-
derived cytokines (IL-1b, TNF-a, IL-8, IL-6, IL-10)
were further normalized to the relative number of
AM. The ratio obtained was considered to be the
relative protein mRNA abundance.
Determination of protein-bound carbonyl
groups
BAL supernatants were kept frozen at 251C until
analysed. Protein-bound carbonyl groups in frozen
samples are stable for at least 2 years (unpublished
results). Carbonyl groups were determined as
described.18 Briefly, aliquots of BAL supernatant
were dialysed against H2O and evaporated to
dryness. Carbonyl groups were reduced to alcoholic
groups by addition of tritiated borohydride (Phar-
macia/Amersham, Germany). To remove tritium
labels different from those in amino acids, the
tritiated proteins were hydrolysed and the amino
acids were separated from carbohydrates by
chromatography on Dowex 50 (Biorad, Germany).18
Protein determination from the acid
hydrolysates
We estimated the protein concentration from the
acid hydrolysates by determining the amount of
amino acids using o -phthalaldehyde as described.18
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The carbonyl content of proteins (oxidized
proteins) was expressed as nmol carbonyl/mg BAL
fluid protein.
Statistics
Statistical analysis was performed using Stat-
graphics plus 4.0. Results were expressed as the
arithmetic mean7SEM. Significant differences be-
tween groups were identified using the non-para-
metric Mann–Whitney test. Correlation coefficients
were determined by the Spearman rank test.
Probability values of o0.05 were considered as
statistically significant.
Results
None of the smoking patients or the patients that
were on prednisone treatment showed a pro-
nounced tendency to differ from the non-smoking
patients in the parameters that were measured.
Therefore for comparison of groups and statistical
evaluation data from all patients were included.
BAL cell counts
Compared to the control group total BAL cell
numbers obtained from both IPF and SARC patients
were elevated 3.5-fold and 5.3-fold, respectively
(Table 1). Increases in total cell numbers in IPF
patients were largely due to an influx of alveolar
macrophages, PMN, and lymphocytes. In SARC
patients, the increases could be ascribed to an
influx of alveolar macrophages and lymphocytes.
BAL fluid protein and their oxidative status
The total protein content of BAL fluid of the control
group was 69 mg/ml (Table 1). This parameter
increased 4-fold in the SARC group, but was normal
in the IPF-group. The oxidative status of the BAL
fluid protein, defined as nmol carbonyl groups/mg
protein, increased 2.4-fold in IPF, and remained
unchanged in the SARC group.
Analysis of enzyme and cytokine mRNA in
BAL cells
Semi-quantitative RT-PCR (Fig. 1) analysis revealed
that BAL cells from both IPF and SARC patients
expressed lower amounts of specific mRNA for the
antioxidant enzymes Mn-SOD (IPF P ¼ 0:033 and
SARC P ¼ 0:083) and GPx (IPF P ¼ 0:062 and SARC
P ¼ 0:003) than control cells (Fig. 2a). By contrast,
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mRNA transcripts of the enzymes iNOS and g-GCS
were neither altered in IPF nor in SARC.
In IPF, mRNA expression for IL-8 and IL-10
markedly increased (P ¼ 0:004 and 0.003, respec-
tively) and decreased for TNF-a (P ¼ 0:02) com-
pared with controls (Figs. 2b and c). In contrast,
BAL cells from SARC patients showed normal IL-8
and TNF-a mRNA levels (P ¼ 0:14 and 0.5, respec-
tively), while the levels of IL-10 mRNA were
elevated (P ¼ 0:003) to a higher extent as in IPF.
ARTICLE IN PRESS
Figure 1 Patterns of enzyme and cytokine mRNA expression in each subject. Using RT-PCR, total RNA was analyzed for
mRNA levels of Mn-SOD, GPx, iNOS, g-GCS, IL-1b, TNF-a, IL-8, IL-6, IL-10, IL-4, and INF-g in BAL cells from control
subjects, IPF and SARC patients. Representative ethidium-stained amplification products of all proteins analyzed by
agarose gel electrophoresis are shown. The numbers represent the individual subject number. The patients with the
numbers 9, 24, 31 and 37 were smokers, and the patients with the numbers 7 and 8 received prednisone before BAL.
Figure 2 Alterations in the relative mRNA abundance. Amplification products from BAL cells of controls, patients with
IPF and patients with SARC were quantified by video densitometry. (a) Mn-SOD, GPx, iNOS, and g-GCS; (b) IL-1b, TNF-a,
and IL-8; (c) IL-6, IL-10, IL-4 and INF-g. All values shown were normalized to the amount (ml) of the RT reaction used in
PCR and to the constitutively expressed mRNA for GAPDH. Data are presented as mean7SEM; *Po0:05:
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The IL-10/IL-8 mRNA ratio was 0.0470.03
(mean7SEM) in controls, 0.0770.02 (P ¼ 0:124) in
IPF patients, and 0.8670.25 (P ¼ 0:003) in SARC
patients, suggesting a prominent role of IL-10 in
SARC. INF-g mRNA levels increased 5-fold
(P ¼ 0:003) in SARC, but were normal in IPF (Fig.
2c). Expression of IL-4 mRNA increased in both
patient groups (P ¼ 0:004 in IPF, and P ¼ 0:007 in
SARC) compared to the control group (Fig. 2c). No
significant differences were observed in the mRNA
expression of IL-1b and IL-6 both in IPF and in SARC
(Figs. 2b and c).
Relationships between oxidized proteins,
enzymes and cytokines
Spearman correlation analysis (Table 2a/b) re-
vealed an inverse relationship between the carbo-
nyl content of BAL fluid proteins and GPx mRNA
levels (r¼0.85, P ¼ 0:036) in IPF and also an
inverse relationship between protein carbonyl and
INF-g mRNA levels (r¼0.78, P ¼ 0:027) in SARC.
Furthermore, IL-10 correlated positively with TNF-a
(r ¼ 0:82; P ¼ 0:044), IL-1b (r ¼ 0:89; P ¼ 0:029),
and IL-8 (r ¼ 0:86; P ¼ 0:036) in IPF and with Mn-
SOD (r ¼ 0:71; P ¼ 0:044) in SARCU
Discussion
Recent studies have postulated a major role of
oxidative stress in the pathogenesis of interstitial
lung diseases.1–5 The present work was aimed to
enlighten the relationship between redox-balance
and inflammatory mechanisms in IPF and SARC.
Among the BAL cells, AM exhibit a pivotal role in
recruitment and activation of inflammatory cells by
releasing different mediators. Major agonists are
IL-1b, TNF-a, and IL-8 as pro-inflammatory media-
tors, the pleiotropic IL-6 which triggers acute phase
reactions, and IL-10 as an anti-inflammatory coun-
terpart. Particularly IL-1b and TNF-a influence the
expression of various pro-inflammatory chemo-
kines.9 In this context, cytokines may have a
substantial impact on the redox imbalance, which
is defined by the net result of radical generating
and consuming enzymes. The redox balance was
identified in the present study by increased con-
centrations of protein carbonyls in the epithelial
lining fluid.
Cytokine mRNA production in BAL cells was
examined as an indication of ongoing cytokine
synthesis within the lungs of IPF and SARC patients
using RT-PCR analysis. Our data indicate that there
is a distinct increase in expression of IL-8 mRNA in
IPF coinciding with increased numbers of PMN. By
contrast, IL-8 expression in SARC stayed at baseline
levels which was consistent with normal numbers of
PMN.
Interestingly, increased levels of IL-10 transcripts
were observed in IPF and to a higher extent in
SARC. Enhanced IL-10 mRNA expression was also
described by other authors for IPF19 and SARC.20
This cytokine efficiently antagonizes pro-inflamma-
tory responses of alveolar macrophages and other
pulmonary cells, e.g. by down-regulating IL-8
expression21 or inhibition of the respiratory
burst activity.22 The IL-10/IL-8 ratio for specific
mRNA expression may provide helpful information
on the anti-inflammatory efficiency of IL-10.
In IPF, the IL-10/IL-8 ratio was low (0.07) and
comparable to the control value (0.04) suggesting
the absence of a substantial anti-inflammatory
response by IL-10. In SARC, however, the high
IL-10/IL-8 ratio of 0.86 implies a strong suppression
of IL-8 message, which might abolish the influx of
PMN and consequently of PMN-mediated oxidative
stress.
Furthermore, the strongly increased expression
of IFN-g mRNA in SARC may have regulatory
consequences on the inflammatory outcome. Simi-
lar changes in IFN-g mRNA production in BAL cells
from SARC patients have been described.20,23
Robson et al.16 reported that IFN-g inhibits IL-1b-
and TNF-a-induced production of IL-8 in human
peritoneal mesothelial cells and thus controls PMN
migration across the mesothelium in vitro and
in vivo. We propose a similar mechanism for
control of PMN migration across the alveolar-
capillary barrier in SARC, which supports the anti-
inflammatory function of IL-10, e.g. in down-
regulating the expression of IL-8. The positive
correlation between IL-10 and Mn-SOD mRNA
qlevels in SARC further contributes to the
coordination of anti-inflammatory and anti-oxidant
mechanisms.
We found no significant changes in the transcript
levels for IL-1b, TNF-a and IL-6 in BAL-cells of
individuals with both diseases. Our data suggest
that the BAL cells were not an important source for
these cytokines at the time at which they were
sampled in the stage of the diseases. Since we have
found at the same time distinctly increased levels
of IL-10, more pronounced in SARC than in IPF, the
expression of IL-1b, TNF-a, and IL-6 may have been
suppressed by IL-10. In contrast to our finding,
several studies have reported increased mRNA
expression of these three cytokines in IPF24 and in
SARC20,24,25 while others confirm our results.19,26
Ziegenhagen et al.24 showed that in progressing but
not in stable IPF and SARC the mRNA levels of TNF-a
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were increased, and in active SARC increased mRNA
levels of TNF-a and IL-6 were found.20,25 Thus,
apart from technical differences in methodology
and detection of mRNA, most likely differences in
the patient populations may explain the apparent
discrepancies.
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Table 2 Spearman rank correlation analysis between the level of each mRNA in patients with (a) IPF and (b)
SARC.
Mn-SOD GPx iNOS GCS IL-1b TNF-a IL-8 IL-6 IL-10 IL-4 INF-g Oxidized
protein
(a) In patients with IPF
Mn-SOD NS 0.69 NS NS NS 0.68 NS NS NS NS NS
0.094 0.10
GPx NS NS NS NS NS NS NS NS NS NS 0.86
0.04*
iNOS 0.68 NS NS NS NS NS NS NS NS NS NS
0.09
GCS NS NS NS NS NS NS NS NS 0.68 NS NS
0.10
IL-1b NS NS NS NS 0.79 0.82 NS 0.89 NS NS NS
0.05 0.04* 0.03*
TNF-a NS NS NS NS 0.79 0.68 NS 0.82 NS NS NS
0.05 0.10 0.04*
IL-8 0.68 NS NS NS 0.82 0.68 NS 0.86 NS NS NS
0.10 0.04* 0.10 0.04*
IL-6 NS NS NS NS NS NS NS NS NS NS NS
IL-10 NS NS NS NS 0.89 0.82 0.86 NS NS NS NS
0.03* 0.04* 0.04*
IL-4 NS NS NS 0.68 NS NS NS NS NS NS NS
0.10
INF-g NS NS NS NS NS NS NS NS NS NS NS
Oxidized protein NS 0.86 NS NS NS NS NS NS NS NS NS
0.04*
(b) In patients with SARC
Mn-SOD NS 0.67 NS NS 0.60 NS NS 0.71 NS NS NS
0.058 0.088 0.044*
GPx NS NS NS NS NS NS NS NS NS NS NS
iNOS 0.67 NS NS NS NS NS NS 0.83 NS NS NS
0.058 0.018*
GCS NS NS NS NS NS 0.67 NS NS NS 0.88 0.67
0.059 0.013* 0.059
IL-1b NS NS NS NS 0.60 NS NS NS 0.67 NS NS
0.090 0.059
TNF-a 0.60 NS NS NS 0.60 0.62 0.72 0.63 NS NS NS
0.088 0.090 0.081 0.043* 0.073
IL-8 NS NS NS 0.67 NS 0.62 NS NS NS NS NS
0.059 0.081
IL-6 NS NS NS NS NS 0.73 NS 0.62 NS NS NS
0.043* 0.081
IL-10 0.71 NS 0.83 NS NS 0.63 NS 0.62 NS NS NS
0.044* 0.018* 0.073 0.081
IL-4 NS NS NS NS 0.67 NS NS NS NS 0.62 0.75
0.059 0.081 0.034*
INF-g NS NS NS 0.88 NS NS NS NS NS 0.62 0.78
0.013* 0.081 0.027*
Oxidized protein NS NS NS 0.67 NS NS NS NS NS 0.75 0.78
0.059 0.034* 0.027*
Data show the correlation coefficient (in italic) and the significance level. NS, P40:1; *Po0:05:
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In IPF, we found a significant increase of the
carbonyl content in the soluble BAL-fluid protein
fraction, demonstrating a pronounced redox im-
balance. This kind of oxidative stress is presumably
based on Fenton-like reactions, which requires
H2O2 and transition metal ions.
27 On the contrary,
the level of oxidized BAL-fluid proteins in SARC was
normal. Transcripts of the antioxidant enzyme Mn-
SOD were markedly reduced in IPF, which might
contribute to increased steady-state levels of O2
.
O2
 triggers reduction of Fe3þ to Fenton-reactive
Fe2þ ,28 which is essentially involved in metal-
catalyzed oxidation of proteins like formation of
protein carbonyls.27 There is evidence for increased
levels of free iron in the blood of IPF patients.29
Assuming that iron is also increased in their alveolar
space the proposed mechanism is very likely.
Though the expression of GPx was not significantly
altered in IPF, its inverse correlation with protein
carbonyls points at a role of this antioxidant
enzyme for H2O2 detoxification. In SARC, the
absence of an oxidative stress response in terms
of carbonyl formation might be explained by
normal Mn-SOD expression thus providing a lower
O2
 steady-state concentration than in IPF. As a
consequence, the potential for reduction of free
Fe3þ to Fe2þ by O2
 might not be sufficient to
support metal-catalyzed protein oxidation via the
Fenton-mechanism even at the significantly low-
ered expression of GPx. Comparison of the specific
carbonyl content in plasma and BAL-fluid in SARC-
patients revealed comparable carbonyl levels
(data not shown). This observation also suggests
the absence of significant oxidative stress in
SARC. However, the marked influx of serum
protein into the alveolar space might obscure
marginally altered redox-processes in the alveolar
space.
The absence of a substantial induction of iNOS
implies that NO does not contribute markedly to
oxidative stress in IPF. This result is in contrast to
the findings by Saleh et al.4 who reported expres-
sion of iNOS in macrophages and PMN from patients
with early to intermediate stages of IPF. The
discrepancy between these findings may originate
from different disease stages of the patient groups
and/or from different analytical procedures used,
namely RT-PCR in BAL cell extracts versus immu-
nohistochemistry in lung sections.4
GSH represents an essential antioxidant in the
lungs.8 Previous studies indicated reduced levels of
GSH in the epithelial lining fluid of IPF patients,30
which has been suggested as a relevant feature in
pathophysiological mechanism of IPF. In SARC GSH
levels were normal.31 Analysis of the specific mRNA
for the heavy subunit of g-GCS as key enzyme in
GSH biosynthesis indicated no altered expression of
this enzyme in IPF or SARC.
General interpretation
In contrast to IPF, distinct anti-inflammatory
mechanisms appear to be activated in SARC, as
indicated by the high expression of IL-10 and INF-g
transcripts. While high levels of IL-8 mRNA are
expressed in IPF, this cytokine does not play a
significant role in SARC. The anti-inflammatory IL-
10 and presumably INF-g seem to prevent an
increased IL-8 expression in SARC thus lowering
the risk of oxidant injury by PMN and maintaining
the redox balance. The level of oxidized BAL-fluid
proteins is markedly increased in IPF compared to
SARC patients, whereas the expression profiles of
the antioxidant enzymes Mn-SOD and GPx do not
show pronounced differences.
Taken together, the redox balance in IPF is
strongly shifted in favour of oxidants, and we
postulate the explicit involvement of an IL-8
dependent mechanism.
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